These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
981 related articles for article (PubMed ID: 17002676)
41. Effects of PHD and HSP90 on erythropoietin production in yak (Bos grunniens) renal interstitial fibroblast-like cells under hypoxia. Cui Y; Li H; Yu SJ; Afedo SY; Bai XF J Mol Histol; 2022 Apr; 53(2):395-411. PubMed ID: 35084636 [TBL] [Abstract][Full Text] [Related]
42. PHD1 interacts with ATF4 and negatively regulates its transcriptional activity without prolyl hydroxylation. Hiwatashi Y; Kanno K; Takasaki C; Goryo K; Sato T; Torii S; Sogawa K; Yasumoto K Exp Cell Res; 2011 Dec; 317(20):2789-99. PubMed ID: 21951999 [TBL] [Abstract][Full Text] [Related]
47. Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes. Göpfert T; Gess B; Eckardt KU; Kurtz A J Cell Physiol; 1996 Aug; 168(2):354-61. PubMed ID: 8707871 [TBL] [Abstract][Full Text] [Related]
48. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites. Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436 [TBL] [Abstract][Full Text] [Related]
50. Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice. Li X; Sutherland S; Takeda K; Fong GH; Lee FS Blood Cells Mol Dis; 2010 Jun; 45(1):9-19. PubMed ID: 20400342 [TBL] [Abstract][Full Text] [Related]
51. Hypoxia-inducible factors in the first trimester human lung. Groenman F; Rutter M; Caniggia I; Tibboel D; Post M J Histochem Cytochem; 2007 Apr; 55(4):355-63. PubMed ID: 17189520 [TBL] [Abstract][Full Text] [Related]
52. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Takeda K; Aguila HL; Parikh NS; Li X; Lamothe K; Duan LJ; Takeda H; Lee FS; Fong GH Blood; 2008 Mar; 111(6):3229-35. PubMed ID: 18056838 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of prolyl hydroxylase domain-containing protein on hypertension/renal injury induced by high salt diet and nitric oxide withdrawal. Dallatu MK; Choi M; Oyekan AO J Hypertens; 2013 Oct; 31(10):2043-9. PubMed ID: 23811999 [TBL] [Abstract][Full Text] [Related]
54. Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors. Wu Y; Jiang Z; You Q; Zhang X Bioorg Med Chem; 2017 Aug; 25(15):3891-3899. PubMed ID: 28625716 [TBL] [Abstract][Full Text] [Related]
55. The HIF pathway and erythrocytosis. Lee FS; Percy MJ Annu Rev Pathol; 2011; 6():165-92. PubMed ID: 20939709 [TBL] [Abstract][Full Text] [Related]
56. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents. Tanaka T; Nangaku M Exp Cell Res; 2012 May; 318(9):1068-73. PubMed ID: 22414872 [TBL] [Abstract][Full Text] [Related]
57. Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells. Katagiri N; Hitomi H; Mae SI; Kotaka M; Lei L; Yamamoto T; Nishiyama A; Osafune K Sci Rep; 2021 Feb; 11(1):3936. PubMed ID: 33594180 [TBL] [Abstract][Full Text] [Related]
58. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2. Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559 [TBL] [Abstract][Full Text] [Related]